| List | Section | Observation |
|---|---|---|
| Peru | 8.2 Cytotoxics | No observations |
| Cuba | 8.3.1 Anticuerpos monoclonales | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: Including quality-assured biosimilars − Diffuse large B-cell lymphoma − Chronic lymphocytic leukaemia − Follicular lymphoma |
| List | Section | Observation |
|---|---|---|
| Peru | 8.2 Cytotoxics | No observations |
| Cuba | 8.3.1 Anticuerpos monoclonales | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: Including quality-assured biosimilars − Diffuse large B-cell lymphoma − Chronic lymphocytic leukaemia − Follicular lymphoma |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |